Information
-
Trademark
-
79255127
-
Serial Number
79255127
-
Registration Number
5999142
-
International Classifications
-
Filing Date
November 23, 2018
5 years ago
-
Registration Date
March 03, 2020
4 years ago
-
Transaction Date
February 06, 2023
a year ago
-
Status Date
March 03, 2020
4 years ago
-
Published for Opposition Date
December 17, 2019
4 years ago
-
Location Date
March 03, 2020
4 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
BUCHANAN WILL, NORA
-
Attorney Docket Number
0641296
Attorney Name
Samantha M. Quimby
Law Office Assigned Location Code
M70
-
Owners
Mark Drawing Code
4000
Mark Identification
FREELINE
Case File Statements
- GS0051: Pharmaceutical, medical and veterinary preparations for prevention, amelioration or treatment of disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, inflammatory or immune system disorders, autoimmune disorders, hepatological disorders, central or peripheral nervous system disorders, ocular or ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular or vascular disorders, endocrine disorders, gastrointestinal disorders, neurological disorders, dermatological disorders, respiratory disorders, urological disorders, cancers or infectious diseases; pharmaceutical, medical and clinical preparations for therapeutic or prophylactic purposes in connection with blood disorders, lysosomal storage disorders, metabolic disorders, inflammatory or immune system disorders, autoimmune disorders, hepatological disorders, central or peripheral nervous system disorders, ocular or ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular or vascular disorders, endocrine disorders, gastrointestinal disorders, neurological disorders, dermatological disorders, respiratory disorders, urological disorders, cancers or infectious diseases; pharmaceutical, medical and clinical preparations for use in treatment, amelioration or prophylaxis of genetic or inherited or non-infectious diseases or disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, inflammatory or immune system disorders, autoimmune disorders, hepatological disorders, central or peripheral nervous system disorders, ocular or ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular or vascular disorders, endocrine disorders, gastrointestinal disorders, neurological disorders, dermatological disorders, respiratory disorders, urological disorders or cancers; pharmaceutical, medical and clinical preparations for treatment, amelioration or prophylaxis of chronic or systemic disease, namely blood disorders, lysosomal storage disorders, metabolic disorders, inflammatory or immune system disorders, autoimmune disorders, hepatological disorders, central or peripheral nervous system disorders, ocular or ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular or vascular disorders, endocrine disorders, gastrointestinal disorders, neurological disorders, dermatological disorders, respiratory disorders, urological disorders or cancers; pharmaceutical, medical and clinical preparations for use in gene therapy for prevention, amelioration or treatment of disorders, namely of blood disorders, lysosomal storage disorders, metabolic disorders, inflammatory or immune system disorders, autoimmune disorders, hepatological disorders, central or peripheral nervous system disorders, ocular or ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular or vascular disorders, endocrine disorders, gastrointestinal disorders, neurological disorders, dermatological disorders, respiratory disorders, urological disorders, cancers or infectious diseases; pharmaceutical, medical and clinical preparations for liver-targeted viral gene therapy; genetic medicines for prevention, amelioration or treatment of disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, inflammatory or immune system disorders, autoimmune disorders, hepatological disorders, central or peripheral nervous system disorders, ocular or ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular or vascular disorders, endocrine disorders, gastrointestinal disorders, neurological disorders, dermatological disorders, respiratory disorders, urological disorders, cancers or infectious disease; preparations for therapeutic delivery of nucleic acids; viral or nucleic acid vectors for therapeutic or prophylactic purposes or preparations containing such vectors; adeno-associated viral gene therapy preparations for prevention, amelioration or treatment of disorders, namely blood disorders, lysosomal storage disorders, metabolic disorders, inflammatory or immune system disorders, autoimmune disorders, hepatological disorders, central or peripheral nervous system disorders, ocular or ophthalmological disorders, muscular disorders, musculoskeletal disorders, bone disorders, cardiovascular or vascular disorders, endocrine disorders, gastrointestinal disorders, neurological disorders, dermatological disorders, respiratory disorders, urological disorders, cancers or infectious diseases
- PM0001: FREE LINE
Case File Event Statements
-
2/6/2023 - a year ago
25 - CHANGE OF NAME/ADDRESS REC'D FROM IB
Type: ADCH
-
8/15/2022 - a year ago
24 - NEW REPRESENTATIVE AT IB RECEIVED
Type: NREP
-
7/24/2020 - 3 years ago
23 - FINAL DECISION TRANSACTION PROCESSED BY IB
Type: FINO
-
7/8/2020 - 3 years ago
22 - FINAL DISPOSITION NOTICE SENT TO IB
Type: FICS
-
7/8/2020 - 3 years ago
21 - FINAL DISPOSITION PROCESSED
Type: FIMP
-
6/3/2020 - 4 years ago
20 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR
-
3/3/2020 - 4 years ago
19 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
12/17/2019 - 4 years ago
18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
12/17/2019 - 4 years ago
17 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
11/27/2019 - 4 years ago
16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
11/12/2019 - 4 years ago
15 - ASSIGNED TO LIE
Type: ALIE
-
11/7/2019 - 4 years ago
14 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
11/6/2019 - 4 years ago
13 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
11/6/2019 - 4 years ago
12 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
11/6/2019 - 4 years ago
11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
6/14/2019 - 5 years ago
10 - REFUSAL PROCESSED BY IB
Type: RFNT
-
5/8/2019 - 5 years ago
9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
5/7/2019 - 5 years ago
8 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
4/17/2019 - 5 years ago
7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
4/16/2019 - 5 years ago
6 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
4/2/2019 - 5 years ago
5 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
3/27/2019 - 5 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/27/2019 - 5 years ago
3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
3/25/2019 - 5 years ago
2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED
Type: LIMI
-
3/21/2019 - 5 years ago
1 - SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Type: SDRC